Virpax Pharmaceuticals Stock Volatility
| VRPX Stock | USD 3.47 0.06 1.70% |
Virpax Pharmaceuticals appears to be very risky, given 3 months investment horizon. Virpax Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0617, which indicates the firm had a 0.0617% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Virpax Pharmaceuticals, which you can use to evaluate the volatility of the company. Please review Virpax Pharmaceuticals' Semi Deviation of 6.64, risk adjusted performance of 0.0661, and Coefficient Of Variation of 1107.26 to confirm if our risk estimates are consistent with your expectations. Key indicators related to Virpax Pharmaceuticals' volatility include:
360 Days Market Risk | Chance Of Distress | 360 Days Economic Sensitivity |
Virpax Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Virpax daily returns, and it is calculated using variance and standard deviation. We also use Virpax's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Virpax Pharmaceuticals volatility.
Virpax |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Virpax Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Virpax Pharmaceuticals at lower prices. For example, an investor can purchase Virpax stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Virpax Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Virpax Stock
| 0.46 | LPTX | Leap Therapeutics Financial Report 20th of May 2024 | PairCorr |
Virpax Pharmaceuticals Market Sensitivity And Downside Risk
Virpax Pharmaceuticals' beta coefficient measures the volatility of Virpax stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Virpax stock's returns against your selected market. In other words, Virpax Pharmaceuticals's beta of 2.2 provides an investor with an approximation of how much risk Virpax Pharmaceuticals stock can potentially add to one of your existing portfolios. Virpax Pharmaceuticals is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Virpax Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Virpax Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Virpax Pharmaceuticals Demand TrendCheck current 90 days Virpax Pharmaceuticals correlation with market (NYSE Composite)Virpax Beta |
Virpax standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 7.46 |
It is essential to understand the difference between upside risk (as represented by Virpax Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Virpax Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in virpax stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Virpax Pharmaceuticals.
Virpax Pharmaceuticals Stock Volatility Analysis
Volatility refers to the frequency at which Virpax Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Virpax Pharmaceuticals' price changes. Investors will then calculate the volatility of Virpax Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Virpax Pharmaceuticals' volatility:
Historical Volatility
This type of stock volatility measures Virpax Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Virpax Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Virpax Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Virpax Pharmaceuticals' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Virpax Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Virpax Pharmaceuticals Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 2.2047 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Virpax Pharmaceuticals will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Virpax Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Virpax Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Virpax stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Virpax Pharmaceuticals has an alpha of 0.5489, implying that it can generate a 0.55 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Virpax Pharmaceuticals Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Virpax Pharmaceuticals Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Virpax Pharmaceuticals is 1620.47. The daily returns are distributed with a variance of 55.59 and standard deviation of 7.46. The mean deviation of Virpax Pharmaceuticals is currently at 5.72. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.63
α | Alpha over NYSE Composite | 0.55 | |
β | Beta against NYSE Composite | 2.20 | |
σ | Overall volatility | 7.46 | |
Ir | Information ratio | 0.08 |
Virpax Pharmaceuticals Stock Return Volatility
Virpax Pharmaceuticals historical daily return volatility represents how much of Virpax Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 7.4561% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6171% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Virpax Pharmaceuticals Volatility
Volatility is a rate at which the price of Virpax Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Virpax Pharmaceuticals may increase or decrease. In other words, similar to Virpax's beta indicator, it measures the risk of Virpax Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Virpax Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | -9.5 B | -10 B | |
| Market Cap | 3.7 M | 3.6 M |
Virpax Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Virpax Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Virpax Pharmaceuticals' price varies over time.
3 ways to utilize Virpax Pharmaceuticals' volatility to invest better
Higher Virpax Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Virpax Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Virpax Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Virpax Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Virpax Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Virpax Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Virpax Pharmaceuticals Investment Opportunity
Virpax Pharmaceuticals has a volatility of 7.46 and is 12.03 times more volatile than NYSE Composite. 65 percent of all equities and portfolios are less risky than Virpax Pharmaceuticals. You can use Virpax Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Virpax Pharmaceuticals to be traded at $3.37 in 90 days.Average diversification
The correlation between Virpax Pharmaceuticals and NYA is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and NYA in the same portfolio, assuming nothing else is changed.
Virpax Pharmaceuticals Additional Risk Indicators
The analysis of Virpax Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Virpax Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Virpax Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0661 | |||
| Market Risk Adjusted Performance | 0.3044 | |||
| Mean Deviation | 5.62 | |||
| Semi Deviation | 6.64 | |||
| Downside Deviation | 6.99 | |||
| Coefficient Of Variation | 1107.26 | |||
| Standard Deviation | 7.3 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Virpax Pharmaceuticals Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Virpax Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Virpax Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Virpax Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Virpax Pharmaceuticals.
When determining whether Virpax Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Virpax Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Virpax Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Virpax Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virpax Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Virpax Stock analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Virpax Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Virpax Pharmaceuticals. If investors know Virpax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Virpax Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.97) | Return On Assets (0.55) | Return On Equity (1.64) |
The market value of Virpax Pharmaceuticals is measured differently than its book value, which is the value of Virpax that is recorded on the company's balance sheet. Investors also form their own opinion of Virpax Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Virpax Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virpax Pharmaceuticals' market value can be influenced by many factors that don't directly affect Virpax Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virpax Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virpax Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virpax Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.